Telefon:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@antikoerper-online.de

LPAR3 Antikörper (Extracellular, N-Term)

Dieser Kaninchen Polyklonal Antikörper detektiert spezifisch LPAR3 in WB. Es zeigt Reaktivität gegenüber Proben von Ratte.
Produktnummer ABIN7886540
1.184,62 €
Zzgl. Versandkosten 20,00 € und MwSt
Lieferung nach: Deutschland
Lieferung in 8 bis 9 Werktagen

Kurzübersicht für LPAR3 Antikörper (Extracellular, N-Term) (ABIN7886540)

Target

Alle LPAR3 Antikörper anzeigen
LPAR3 (Lysophosphatidic Acid Receptor 3 (LPAR3))

Reaktivität

  • 44
  • 30
  • 12
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
Ratte

Wirt

  • 47
Kaninchen

Klonalität

  • 47
Polyklonal

Konjugat

  • 23
  • 2
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
Dieser LPAR3 Antikörper ist unkonjugiert

Applikation

  • 19
  • 17
  • 16
  • 13
  • 13
  • 9
  • 8
  • 7
  • 3
  • 3
  • 1
  • 1
Western Blotting (WB)
  • Bindungsspezifität

    • 16
    • 4
    • 2
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    AA 16-29, Extracellular, N-Term

    Verwendungszweck

    A Rabbit Polyclonal Antibody to LPA Receptor 3 (EDG7)

    Kreuzreaktivität

    Human, Maus, Ratte

    Homologie

    Mouse - identical, human - 12,14 amino acid residues identical

    Produktmerkmale

    Anti-LPAR3 (EDG7) (extracellular) Antibody (ABIN7043314, ABIN7044570 and ABIN7044571) is a highly specific antibody directed against an epitope to the rat LPA3 receptor. The antibody can be used in western blot analysis. It recognizes an extracellular epitope and is thus ideal for detecting the receptor in living cells. It has been designed to recognize LPA3 receptor from mouse, rat, and human samples.

    Aufreinigung

    Affinity purified on immobilized antigen.

    Immunogen

    (C)RSNTDTADEWTGTK, corresponding to amino acid residues 16-29 of rat LPA3 receptor

    Isotyp

    IgG
  • Applikationshinweise

    WB: 1:200

    FC: The optimal concentration should be determined by the user

    ICC: The optimal concentration should be determined by the user

    IHC: The optimal concentration should be determined by the user

    IP: The optimal concentration should be determined by the user

    Kommentare

    Negative Control: (ABIN7235904)

    Blocking Peptide: (ABIN7235904)

    Beschränkungen

    Nur für Forschungszwecke einsetzbar
  • Format

    Lyophilized

    Rekonstitution

    25 μL, 50 μL or 0.2 mL double distilled water (DDW), depending on the sample size.

    Konzentration

    0.8 mg/mL

    Buffer

    PBS pH 7.4, 1 % BSA with 0.05 % sodium azide

    Konservierungsmittel

    Sodium azide

    Vorsichtsmaßnahmen

    This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

    Lagerung

    -20 °C

    Informationen zur Lagerung

    The antibody ships as a lyophilized powder at room temperature. Upon arrival, it should be stored at -20°C
  • Target

    LPAR3 (Lysophosphatidic Acid Receptor 3 (LPAR3))

    Andere Bezeichnung

    LPAR3

    Hintergrund

    Synonyms: Lysophosphatidic acid receptor 3, LPA receptor 3, LPA-3, snGPCR32

    Description: Lysophosphatidic acid (LPA) is a bioactive lipid molecule with a phosphate, a glycerol, and a fatty acid in its structure. The cellular effects of LPA include proliferation, migration, cytokine secretion, and morphological change. These pleiotropic actions allow LPA to participate in a wide variety of biological processes, such as brain development, oncogenesis, wound healing and cancer progression1. To date, at least 6 subtypes of LPA receptors have been identified. The LPA1-3 receptors are members of the endothelial cell differentiation gene (Edg) family2. All six receptors are type I, rhodopsin-like G-protein coupled receptors (GPCRs) that differ in their tissue distribution and downstream signaling pathways3.GPCRs share a similar topology, with seven transmembrane helices (TMHs) connected by three extracellular loops (ECLs), and three intracellular loops (ICLs), the N-terminus is on the extracellular side of the membrane, and the C-terminus is on the cytoplasmic side4.Expression of LPA3 receptor has been observed in human heart, testis, prostate, pancreas, lung, ovary, and brain5 and is most abundant in mouse testis, kidney, lung, small intestine, heart, stomach, spleen, brain, and thymus6.LPA3 receptor null mice are viable and grossly normal, but female nulls show a striking phenotype in the reproductive system7. However, despite the fact that LPA3 is expressed in the frontal cortex, hippocampus, and amygdala, no phenotypes related to LPA3 loss in the nervous system have been reported to date5.

    Gen-ID

    66025

    NCBI Accession

    NM_012152

    UniProt

    Q8K5E0

    Pathways

    Regulation of Cell Size
Sie sind hier:
Chat with us!